获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Institute of Cancer Research

七月 2026

  • Home
  • Institute of Cancer Research

七月 2026的Institute of Cancer Rese...市场份额分析

The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003.
成立年份1909
员工1001 - 5000
年营收$200M - $500M
icr.ac.uk
Institute of Cancer Research
Institute of Cancer Research(包含公司地区分支机构)
  • icr.ac.uk
    icr.ac.uk
查看更多网站流量和参与度信息

Institute of Cancer Research收入截至 七月 2026为 200M - 500M

Institute of Cancer Research主要域名产生的收入

3 年中Institute of Cancer Research主要域名的收入

Institute of Cancer Research主要域名的收入


Institute of Cancer Research热门域名的总访问量

了解Institute of Cancer Research市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Institute of Cancer Research热门域名的平均访问时长

分析Institute of Cancer Research参与度指标。

过去 3 个月的平均访问时长

子公司明细

Institute of Cancer Research热门域名的平均页面浏览量

了解Institute of Cancer Research如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Institute of Cancer Research 采用的主要技术

这些是排名前 Institute of Cancer Research 的顶级域名所使用的网站技术(按行业分列)

付费广告 (18)

Google Adsense

Google Adsense

付款和货币 (12)

转化和分析 (9)

Google Analytics

Google Analytics

电子商务 (6)

更多技术

13

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Institute of Cancer Research 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻The Institute of Cancer Research is developing drug candidates.The team are working with the Centre for Cancer Drug Discovery at the ICR, to develop and improve new drug candidates that target RNA modification pathways similar to those mediated by TUT4/7.
新闻The Institute of Cancer Research is developing potent small-molecule inhibitors of DHX8 on Aug 7th '26.(IN BRIEF) Researchers at The Institute of Cancer Research, London, working with Merck KGaA, have developed the first potent small-molecule inhibitors of DHX8, an enzyme involved in pre-mRNA splicing.
新闻The Institute of Cancer Research partnered with Merck KGaA on Aug 7th '26.Now, scientists at The Institute of Cancer Research (ICR), in collaboration with Merck KGaA, have shown that the function of DHX8 can be inhibited directly with small molecules.

查看 Institute of Cancer Research 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。